These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 21565676

  • 1. Blood pressure effects of the oral contraceptive and postmenopausal hormone therapies.
    Boldo A, White WB.
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):419-32, ix. PubMed ID: 21565676
    [Abstract] [Full Text] [Related]

  • 2. Effects of hormone replacement therapy or raloxifene on ambulatory blood pressure and arterial stiffness in treated hypertensive postmenopausal women.
    da Costa LS, de Oliveira MA, Rubim VS, Wajngarten M, Aldrighi JM, Rosano GM, Neto CD, Gebara OC.
    Am J Cardiol; 2004 Dec 01; 94(11):1453-6. PubMed ID: 15566926
    [Abstract] [Full Text] [Related]

  • 3. Effects of hormone therapy on blood pressure and the renin-angiotensin system in postmenopausal women.
    Prime DD, Brosnihan KB, Herrington DM.
    Minerva Cardioangiol; 2007 Aug 01; 55(4):477-85. PubMed ID: 17653023
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J, Sumino H, Ichikawa S, Ozaki M.
    Am J Hypertens; 2006 Jul 01; 19(7):744-9. PubMed ID: 16814131
    [Abstract] [Full Text] [Related]

  • 6. Effects of raloxifene on the renin-angiotensin-aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women.
    Sumino H, Ichikawa S, Kasama S, Takahashi T, Kumakura H, Takayama Y, Kanda T, Murakami M, Kurabayashi M.
    Geriatr Gerontol Int; 2010 Jan 01; 10(1):70-7. PubMed ID: 20102385
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Hormonal contraception and hypertension].
    Hamann KM, Faulhaber HD, Hamann B.
    Z Arztl Fortbild (Jena); 1982 Mar 01; 76(5):198-201. PubMed ID: 7080544
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
    Bjarnason NH.
    Dan Med Bull; 2005 May 01; 52(2):64-81. PubMed ID: 16009050
    [No Abstract] [Full Text] [Related]

  • 10. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE.
    Acta Endocrinol (Copenh); 1991 May 01; 125 Suppl 1():13-26. PubMed ID: 1801500
    [Abstract] [Full Text] [Related]

  • 11. Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women.
    Morgante G, Delia A, Musacchio MC, Severi FM, Petraglia F, De Leo V.
    Gynecol Endocrinol; 2006 Jul 01; 22(7):376-80. PubMed ID: 16864147
    [Abstract] [Full Text] [Related]

  • 12. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr 01; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 13. [Hormonal contraceptives and arterial hypertension].
    Janaszek-Sitkowska H.
    Pol Tyg Lek; 1991 Apr 01; 39(40-41):1341-3. PubMed ID: 6393087
    [Abstract] [Full Text] [Related]

  • 14. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
    Ichikawa A, Sumino H, Ogawa T, Ichikawa S, Nitta K.
    Geriatr Gerontol Int; 2008 Dec 01; 8(4):259-64. PubMed ID: 19149837
    [Abstract] [Full Text] [Related]

  • 15. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH.
    Climacteric; 2005 Oct 01; 8 Suppl 3():19-27. PubMed ID: 16203652
    [Abstract] [Full Text] [Related]

  • 16. Randomized, controlled study of the effects of raloxifene on high sensitivity C-reactive protein and serum lipids.
    Oztas E, Kurtay G.
    Arch Gynecol Obstet; 2011 Jan 01; 283(1):71-7. PubMed ID: 20012308
    [Abstract] [Full Text] [Related]

  • 17. Hypertension in women.
    August P.
    Adv Chronic Kidney Dis; 2013 Sep 01; 20(5):396-401. PubMed ID: 23978544
    [Abstract] [Full Text] [Related]

  • 18. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M, Akan P, Dogan E, Karas C, Saygili U, Posaci C.
    Maturitas; 2006 Feb 20; 53(3):252-9. PubMed ID: 15990257
    [Abstract] [Full Text] [Related]

  • 19. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis].
    Urano T.
    Clin Calcium; 2005 Apr 20; 15(4):591-5. PubMed ID: 15802770
    [Abstract] [Full Text] [Related]

  • 20. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H, de Moerloose P, Campana A.
    Schweiz Med Wochenschr; 1996 Oct 12; 126(41):1756-63. PubMed ID: 8966508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.